Literature DB >> 7019041

Interleukin-2 dependent culture of cytolytic T cell lines.

S Gillis, J Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7019041     DOI： 10.1111/j.1600-065x.1981.tb00435.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  24 in total

1.  Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.

Authors:  B Genç; H Müller-Hartmann; M Zeschnigk; H Deissler; B Schmitz; F Majewski; A von Gontard; W Doerfler
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Dietary protein deficiency and Mycobacterium bovis BCG affect interleukin-2 activity in experimental pulmonary tuberculosis.

Authors:  D N McMurray; C L Mintzer; R A Bartow; R L Parr
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Failure of exogenous interleukin 1 and interleukin 2 to correct decreased lymphocyte transformation in chronic hepatitis B virus carriers.

Authors:  C Anastassakos; G J Alexander; R A Wolstencroft; D C Dumonde; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  HLA class I specific T lymphocyte clones with dual alloreactive functions.

Authors:  N Flomenberg; C Russo; S Ferrone; B Dupont
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis.

Authors:  A Van Pel; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.

Authors:  A R Pachner; F S Kantor
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

10.  Induction of a B-lymphocyte receptor for a T cell-replacing factor by the crosslinking of surface IgD.

Authors:  L J Yaffe; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.